Screener
Kura Oncology KURA Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
FAQ
- What is Kura Oncology's invested capital?
- Kura Oncology (KURA) reported invested capital of $93.07M in Q1 2026.
- How has Kura Oncology's invested capital changed year-over-year?
- Kura Oncology's invested capital decreased by 72.0% year-over-year, from $332.49M to $93.07M.
- What is the long-term trend for Kura Oncology's invested capital?
- Over 5 years (2020 to 2025), Kura Oncology's invested capital has grown at a -31.4% compound annual growth rate (CAGR), from $300.36M to $45.49M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Kura Oncology's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude